Ira Duarte is EVP, Chief Financial Officer of HERON THERAPEUTICS, INC. . Currently has a direct ownership of 108,001 shares of HRTX, which is worth approximately $170,641. The most recent transaction as insider was on Oct 19, 2024, when has been sold 3,874 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 108K
3.72% 3M change
27.06% 12M change
Total Value Held $170,641

Ira Duarte Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 19 2024
BUY
Exercise of conversion of derivative security
-
3,874 Added 3.46%
108,001 Common Stock
Jul 19 2024
BUY
Exercise of conversion of derivative security
-
3,875 Added 3.59%
104,127 Common Stock
Jun 16 2024
BUY
Exercise of conversion of derivative security
-
12,500 Added 11.09%
100,252 Common Stock
Apr 19 2024
SELL
Payment of exercise price or tax liability
$2,962 $2.64 p/Share
1,122 Reduced 1.26%
87,752 Common Stock
Apr 19 2024
BUY
Exercise of conversion of derivative security
-
3,874 Added 4.18%
88,874 Common Stock
Nov 16 2023
BUY
Open market or private purchase
$75,650 $0.89 p/Share
85,000 Added 50.0%
85,000 Common Stock

Also insider at

TRSSF
TerrAscend Corp. Healthcare
ID

Ira Duarte

EVP, Chief Financial Officer
Mississauga, A6

Track Institutional and Insider Activities on HRTX

Follow HERON THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRTX shares.

Notify only if

Insider Trading

Get notified when an Heron Therapeutics, Inc. insider buys or sells HRTX shares.

Notify only if

News

Receive news related to HERON THERAPEUTICS, INC.

Track Activities on HRTX